Daily Briefing
Sunday, February 22, 2026
The Vibe
AI is beating human trainees in emergency radiology while sophisticated blood cancer diagnostics emerge from bone marrow analysis [1][2]. The real story isn't just diagnostic accuracy—it's that AI models are now performing better than residents in high-stakes, time-pressured clinical scenarios where mistakes kill patients.
Research
•Commercial AI software outperformed on-call radiology residents in detecting intracranial hemorrhage on emergency CT scans, marking a turning point where AI exceeds junior physician performance in critical diagnosis [1]
•Deep learning model successfully differentiated prefibrotic primary myelofibrosis from essential thrombocythemia using digitized bone marrow biopsies, solving a notoriously difficult hematologic differential that stumps pathologists [2]
•AI analysis of carotid ultrasound features enhanced prediction of vulnerable plaques associated with acute ischemic stroke, potentially identifying high-risk patients before they suffer cerebrovascular events [3]
•Routine MRI-based AI model accurately assessed cerebrovascular anatomy for pre-surgical intracranial tumor planning across multiple centers, offering angiography-level information without invasive procedures [4]
Blogs
•OpenAI shares its first attempts at formal mathematical proofs through the First Proof challenge, testing whether AI can handle expert-level reasoning in research mathematics—a harbinger for clinical reasoning benchmarks [5]
Podcasts (Hot Takes)
•Nikhil Buduma from Ambience Healthcare makes the case that AI adoption in clinical workflows finally has CFO-converting ROI data, not just clinical performance metrics—this shift from "cool technology" to "measurable business value" explains why academic medical centers are actually implementing these tools [6]
YouTube (Hot Takes)
•Harvard's Joia Mukherjee discusses global health work spanning infectious disease and pediatrics—while not AI-focused, her approach to systematic health delivery in resource-constrained settings offers lessons for deploying diagnostic AI in low-resource environments [7]
•AMA's nursing home safety discussion addresses infection control protocols, relevant as AI-driven monitoring systems increasingly track patient acuity and room assignments in long-term care facilities [8]
Clinical Practice & Ops
•AstraZeneca's FDA approval for fixed-duration Calquence plus Venclexta combination represents the first all-oral, time-limited treatment regimen for CLL, shifting away from indefinite therapy protocols [9]
•Supreme Court ruling struck down emergency tariffs affecting pharmaceutical manufacturing, providing regulatory certainty for medical device and AI hardware supply chains [10]
Industry & Products
•Grail's Galleri blood test failed to achieve statistical significance in a large cancer screening study, causing shares to drop 50% and raising questions about multi-cancer detection viability despite trending improvements [11][12]
One to Watch
Monitor whether emergency departments start replacing resident preliminary reads with AI triage, fundamentally changing radiology training paradigms.